排序方式: 共有7条查询结果,搜索用时 0 毫秒
1
1.
Keser Tobias Kofler Mario Katzmayr Mariella Schiefecker Alois J. Rass Verena Ianosi Bogdan A. Lindner Anna Gaasch Maxime Beer Ronny Rhomberg Paul Schmutzhard Erich Pfausler Bettina Helbok Raimund 《Neurocritical care》2020,33(1):132-139
Neurocritical Care - Despite the tremendous impact of swallowing disorders on outcome following ischemic stroke, little is known about the incidence of dysphagia after subarachnoid hemorrhage (SAH)... 相似文献
2.
Alberto Addis Maxime Gaasch Alois J Schiefecker Mario Kofler Bogdan Ianosi Verena Rass Anna Lindner Gregor Broessner Ronny Beer Bettina Pfausler Claudius Thom Erich Schmutzhard Raimund Helbok 《Journal of cerebral blood flow and metabolism》2021,41(2):359
Elevated body temperature (Tcore) is associated with poor outcome after subarachnoid hemorrhage (SAH). Brain temperature (Tbrain) is usually higher than Tcore. However, the implication of this difference (Tdelta) remains unclear. We aimed to study factors associated with higher Tdelta and its association with outcome. We included 46 SAH patients undergoing multimodal neuromonitoring, for a total of 7879 h of averaged data of Tcore, Tbrain, cerebral blood flow, cerebral perfusion pressure, intracranial pressure and cerebral metabolism (CMD). Three-months good functional outcome was defined as modified Rankin Scale ≤2. Tbrain was tightly correlated with Tcore (r = 0.948, p < 0.01), and was higher in 73.7% of neuromonitoring time (Tdelta +0.18°C, IQR −0.01 – 0.37°C). A higher Tdelta was associated with better metabolic state, indicated by lower CMD-glutamate (p = 0.003) and CMD-lactate (p < 0.001), and lower risk of mitochondrial dysfunction (MD) (OR = 0.2, p < 0.001). During MD, Tdelta was significantly lower (0°C, IQR −0.2 – 0.1; p < 0.001). A higher Tdelta was associated with improved outcome (OR = 7.7, p = 0.002). Our study suggests that Tbrain is associated with brain metabolic activity and exceeds Tcore when mitochondrial function is preserved. Further studies are needed to understand how Tdelta may serve as a surrogate marker for brain function and predict clinical course and outcome after SAH. 相似文献
3.
4.
Rass Verena Solari Daria Ianosi Bogdan Gaasch Max Kofler Mario Schiefecker Alois J. Miroz John-Paul Morelli Paola Thomé Claudius Beer Ronny Pfausler Bettina Oddo Mauro Helbok Raimund 《Neurocritical care》2019,31(2):263-272
Neurocritical Care - Brain tissue hypoxia (PbtO2 < 20 mmHg) is common after subarachnoid hemorrhage (SAH) and associated with poor outcome. Recent data suggest that... 相似文献
5.
6.
Gimenez-Arnau A Pujol RM Ianosi S Kaszuba A Malbran A Poop G Donado E Perez I Izquierdo I Arnaiz E;Rupatadine Urticaria Study Group 《Allergy》2007,62(5):539-546
BACKGROUND: Chronic urticaria is one of the most common and disturbing cutaneous condition. The treatment of chronic idiopathic urticaria (CIU) is still a challenge. Antihistamines are recommended as first-line treatment. Rupatadine is a new potent nonsedative anti-H1. OBJECTIVE: To study rupatadine efficacy and safety for moderate to severe CIU treatment. METHODS: This randomized, double-blind, placebo-controlled, parallel-group, multicentre, study was designed to assess primarily mean pruritus score (MPS) reduction with rupatadine, 10 and 20 mg, administered once daily for 4 weeks. Three hundred and thirty-three patients with active episodes of moderate-to-severe CIU were included. RESULTS: A 57.5% (P < 0.005) and 63.3% (P = 0.0001) significative MPS reduction from baseline, was observed at week 4 with 10 and 20 mg rupatadine, respectively, compared with placebo (44.9%). Both doses of rupatadine were not significantly different at any time point, with respect to their effects on pruritus severity, number of wheals and total symptoms scores. Rupatadine 10 mg had an overall better adverse event profile. CONCLUSION: Rupatadine 10 mg is a fast, long-acting, efficacious and safe treatment option for the management of patients with moderate-to-severe CIU. 相似文献
7.
Rass Verena Schoenherr Elisabeth Ianosi Bogdan-Andrei Lindner Anna Kofler Mario Schiefecker Alois J. Lenhart Lukas Gaasch Max Pertl Marie-Theres Freyschlag Christian F. Pfausler Bettina Delazer Margarete Beer Ronny Thomé Claudius Grams Astrid Ellen Scherfler Christoph Helbok Raimund 《Neurocritical care》2020,32(2):492-501
Neurocritical Care - Subarachnoid hemorrhage (SAH) is a devastating disease associated with high mortality and morbidity. Besides neurological sequelae, neuropsychological deficits largely... 相似文献
1